Latest Pharmaceutical Industry Trends in India: Growing Demand for Oncology Medicines and Global Pha

In the pharmaceutical sector, India continues to expand its capabilities in specialty and oncology medicines, with Delhi becoming a key hub for pharmaceutical manufacturing, distribution, and B2B medicine supply. With the need for cancer treatments growing, access to high-quality oncology treatments is becoming increasingly crucial for hospitals, distributors, healthcare providers, and buyers of international pharmaceuticals. The most important medications used in oncology are Azacitidine and bendamustine. Items like AZACBUZZ 100 mg injection from Delhi , as well as Bendamustine 100 mg injection in Delhi, are pharmaceutical formulations that are specifically designed and require proper manufacturing, storage, quality control, and distribution methods. Growing Importance of Oncology Medicines in India The treatment of cancer is a complicated sector of healthcare that usually requires multiple treatment approaches. Based on the type of cancer and the therapy plan for patients, they coul...

The pharmaceutical industry will undergo major changes in 2026 as India increases its position as a key world supplier of pharmaceuticals. The rising demand for generic drugs, specialty therapies, oncology products, and pharmaceutical formulations is providing new opportunities for manufacturers and exporters. Businesses are more focused on quality, regulatory compliance, supply-chain resilience, and the expansion of international markets. The pharmaceutical exports of India topped 31 billion dollars in FY 2025-26, which shows India's importance in the supply of medicines worldwide despite trade and geopolitical challenges. India's Pharmaceutical Industry Moves Toward Complex Therapies One of the biggest trends in the pharmaceutical industry is the increasing demand for special and complex drugs. Although generic drugs are a significant part of the Indian pharmaceutical industry, the manufacturers are increasing their offerings into oncology, biosimilars, specialty drugs and ot...